Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on pharma, health law, and policy issues from August 2020.

Interesting empirical studies, policy analyses, and editorials on pharma, health law, and policy issues from August 2020.

Physicians have a right to share their lives on social media. If we hold otherwise, then professionalism becomes a method of controlling behavior.

Government authorities must be extremely cautious about basing public policy decisions on inadequately vetted findings, no matter how much hype they get.

By Nir Eyal On Wednesday, South African Health Minister Aaron Motsoaledi announced that, as of January 2015, HIV-positive patients in the country would start receiving free antiretroviral treatment once their CD4 count fell below 500, instead of current threshold of less than 350. Some patient groups would start receiving antiretrovirals immediately upon being diagnosed with…
By Scott Burris The most important topic we did NOT address in our PHLR methods book was valid methods for rating laws for characteristics like “stringency.” I am not aware of any general work on this. Nonetheless, it is not uncommon for researchers to create scales purporting to measure the distribution of some characteristic(s) over…